Strive, Inc. Ratifies Highly Dilutive Equity Plan, Authorizing Over 118M Shares and Large CEO Grant
ASST has more than doubled off its 52-week low of $0.387.
Summary
Strive, Inc. stockholders ratified a new equity incentive plan authorizing a substantial number of shares, including an evergreen provision for annual increases and a significant $17 million RSU grant for the CEO, indicating considerable future dilution.
Key Events · Financing and Capital Events · ASST
-
New Equity Incentive Plan Approved
Majority stockholders ratified the 2026 Omnibus Equity Incentive Plan, replacing the prior plan, following board approval.
-
Significant Share Authorization
The plan initially authorizes 118,459,736 shares of Class A Common Stock for awards, representing a substantial portion of the company's current outstanding shares.
-
Annual Evergreen Provision
The plan includes an evergreen provision allowing for annual increases of up to 5% of the fully diluted outstanding shares, posing a continuous dilution risk to existing shareholders.
-
Large CEO Equity Grant
The CEO, Matthew Cole, is recommended to receive a restricted stock unit grant valued at $17,000,000, a material award relative to the company's market capitalization.
Analysis · ASST · Crypto Assets
The ratification of the 2026 Omnibus Equity Incentive Plan is a highly significant event for Strive, Inc. due to the substantial potential for dilution. The initial authorization of over 118 million shares, coupled with an evergreen provision for annual increases of up to 5% of fully diluted shares, represents a considerable overhang on the stock and could significantly dilute existing shareholder value over time. Furthermore, the recommended $17 million RSU grant for the CEO is a very large individual compensation package. While equity plans are common for employee retention, the scale of this authorization and the evergreen clause are particularly noteworthy for a company of this size. Investors should monitor the actual issuance of shares under this plan and its impact on per-share metrics. The company's "controlled company" status also highlights a governance structure where majority shareholders can approve such actions without broader shareholder consent.
At the time of this filing, ASST was trading at $0.91 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $850.6M. The 52-week trading range was $0.39 to $13.42. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.